Proton cancer therapy set for launch in Qatar
Dubai, January 30, 2010
The Qatar National Cancer Society and SAH Global have signed a memorandum of understanding to make the next generation of cancer treatment, proton therapy, available to cancer patients in Qatar.
The agreement, the first of its kind in the Middle East, promises to promote proton therapy as the primary treatment for cancer patients in Qatar.
Through this agreement, Qatari citizens and residents will gain access to a cutting edge cancer treatment that provides a higher quality of life and fewer side effects to those suffering from cancer, a statement said.
SAH Global’s subsidiary SAH Care will coordinate end-to-end treatment through its arrangements with proton therapy centers around the world as of second quarter 2010.
Consequently, Qatari patients will receive high-quality care and service through all aspects of treatment and travel. Even though waiting time for treatment can exceed three months in many cases, Qatari cancer patients will benefit from SAH Care’s network of providers to reduce time-to-treatment to a matter of weeks.
“With the signing of the agreement today we have reached a major milestone in the fight against cancer,” said Dr Khalid Bin Jabor Al-Thani, chairman of the Qatar National Cancer Society (QNCS).
“The QNCS is committed to educating and helping cancer patients in their fight against cancer and this agreement will help us to further our goals and provide a higher quality of life for cancer patients from Qatar,” he added.
Feroz Agad, CEO of SAH Global said: “We believe this is the first critical step in creating awareness for this cutting edge and proven technology. We commend Dr Khalid and the Qatar National Cancer Society for their visionary leadership in working to bring Proton Therapy to the people of Qatar.”
SAH Global is in the process of making cutting edge cancer treatments available to the Middle East.
Additionally, SAH Global is committed to bringing next generation cancer treatments to the Middle East and is working with RHT Partners, a leading independent investment management firm, and other advisors to review the opportunity to build an initial flagship proton therapy centre in the region.
SAH Global plans to build a network of proton centres in the Middle East in order to better serve the growing number of cancer patients. – TradeArabia News Service